Low level CD20 expression on T cell malignancies
- PMID: 7523045
- DOI: 10.1002/cyto.990180206
Low level CD20 expression on T cell malignancies
Abstract
Although initially thought to be a B lineage restricted antigen, low "density" or antibody binding capacity (ABC) CD20 has recently been detected on subset(s) of normal T lymphocytes (Hultin et al.: Cytometry 14:196-204, 1993). We report low ABC CD20 expression in three (two children, one adult) cases of T-acute lymphoblastic leukemia (T-ALL). CD20 and other pertinent antigens were detected using a direct dual color method with a Becton Dickinson FACScan flow cytometer and Simulset software. Only one cell population based on light scatter was noted in each case that immunophenotypically represented almost a pure population of malignant cells expressing T lymphocyte antigens (for example, CD7 98%, 92%, and 100%, respectively). A total of 95%, 87%, and 79% of the cells from the three cases expressed CD20 with an unusual low ABC compared to the customary "bright" CD20 expression on normal B lymphocytes. Other B lymphocyte associated antigens, such as CD19, CD22, Dr, and immunoglobulin light chains, were negative. Eleven other T lymphocytic malignancies from 1991 to 1993 were CD20 negative, including three other case of T-ALL (one adult and two children). One unusual case of intestinal small lymphocytic non-Hodgkin's lymphoma with a natural killer/T lymphocytic immunophenotype not described in this report appeared to be CD20"dim"+. Low ABC CD20 expression by T lymphocytic malignancies may provide a more unique immunophenotypic "fingerprint" to help support the diagnosis of T cell neoplasia vs. normal/reactive T cells (for example, low ABC CD20 cells represent only 2.4 +/- 1.5% of normal peripheral blood lymphocytes). This characteristic might also facilitate monitoring patients for residual or recurrent disease.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
[Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].Ai Zheng. 2007 Apr;26(4):418-22. Ai Zheng. 2007. PMID: 17430665 Chinese.
-
CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes.Cytometry. 1993;14(2):196-204. doi: 10.1002/cyto.990140212. Cytometry. 1993. PMID: 7679964
-
Automatic lineage assignment of acute leukemias by flow cytometry.Cytometry. 1993 Nov;14(8):862-75. doi: 10.1002/cyto.990140804. Cytometry. 1993. PMID: 7507022
-
CD3-negative, CD20-positive T-cell prolymphocytic leukemia: case report and review of the literature.Am J Hematol. 2002 Dec;71(4):331-5. doi: 10.1002/ajh.10224. Am J Hematol. 2002. PMID: 12447967 Review.
-
Hodgkin's disease, mixed cellularity type, with a B-cell immunophenotype. Report of a case and literature review.Arch Pathol Lab Med. 1995 May;119(5):474-9. Arch Pathol Lab Med. 1995. PMID: 7538289 Review.
Cited by
-
CD20-positive NK/T-cell lymphoma with indolent clinical course: report of case and review of literature.Diagn Pathol. 2012 Oct 2;7:133. doi: 10.1186/1746-1596-7-133. Diagn Pathol. 2012. PMID: 23031227 Free PMC article. Review.
-
CD20 positive T cell lymphoma: is it a real entity?J Clin Pathol. 2004 Apr;57(4):442-4. doi: 10.1136/jcp.2003.011734. J Clin Pathol. 2004. PMID: 15047755 Free PMC article. Review.
-
CD20 Positive T Cell Lymphoma Involvement of Skin.Ann Dermatol. 2011 Nov;23(4):529-35. doi: 10.5021/ad.2011.23.4.529. Epub 2011 Nov 3. Ann Dermatol. 2011. PMID: 22148028 Free PMC article.
-
Rituximab resistance.Best Pract Res Clin Haematol. 2011 Jun;24(2):203-16. doi: 10.1016/j.beha.2011.02.009. Epub 2011 Apr 13. Best Pract Res Clin Haematol. 2011. PMID: 21658619 Free PMC article. Review.
-
CD20-positive primary gastric T-cell lymphoma poorly responding to initial treatment with rituximab plus CHOP, and a literature review.Int J Hematol. 2015 Dec;102(6):702-8. doi: 10.1007/s12185-015-1841-x. Epub 2015 Aug 7. Int J Hematol. 2015. PMID: 26251099 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources